مؤتمر
Cessation of nucleos(t)ide analogue treatment after HBeAg seroconversion is associated with a 4-fold increased risk of relapse in cirrhotic compared to non-cirrhotic patients
| العنوان: | Cessation of nucleos(t)ide analogue treatment after HBeAg seroconversion is associated with a 4-fold increased risk of relapse in cirrhotic compared to non-cirrhotic patients |
|---|---|
| المؤلفون: | Van Hees, S, Bourgeois, S, Van Vlierberghe, H, Sersté, T, Francque, S, Michielsen, P, Sprengers, D, Reynaert, H, Henrion, J, Negrin Dastis, S, DELWAIDE, Jean, Lasser, L, Decaestecker, J, Orlent, H, Janssens, F, Robaeys, G, Colle, I, Starkel, P, Moreno, C, Nevens, F, Vanwolleghem, T |
| المصدر: | Hepatology, 66 (S1), A934 (2017-10); Liver Meeting American Association for the Study of Liver Diseases, Washington, United States [US], du 20 octobre 2017 au 24 octobre 2017 |
| بيانات النشر: | Wiley, 2017. |
| سنة النشر: | 2017 |
| مصطلحات موضوعية: | Human health sciences, Gastroenterology & hepatology, Sciences de la santé humaine, Gastroentérologie & hépatologie |
| نوع الوثيقة: | conference paper http://purl.org/coar/resource_type/c_5794 conferenceObject peer reviewed |
| اللغة: | English |
| Relation: | urn:issn:0270-9139; urn:issn:1527-3350 |
| URL الوصول: | https://orbi.uliege.be/handle/2268/215632 |
| حقوق: | open access http://purl.org/coar/access_right/c_abf2 info:eu-repo/semantics/openAccess |
| رقم الأكسشن: | edsorb.215632 |
| قاعدة البيانات: | ORBi |
| الوصف غير متاح. |